相关实验视频

Updated: Jul 8, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

基于氧化还原反应的多糖基纳米结构的近期进展用于癌症治疗

Jian Li¹, Jinsong Wang¹, Yang Huang¹

¹Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources and International Innovation Center for Forest Chemicals and Materials, Nanjing Forestry University, Nanjing 210037, China.

Carbohydrate polymers

|February 19, 2026

概括

本综述探讨了使用多糖胺来克服化疗局限性的氧化回应纳米药物输送系统. 这些系统利用瘤微环境条件来向药物释放,提高疗效和减少副作用.

科学领域:

生物材料科学生物材料科学
纳米技术纳米技术
在瘤学瘤学.

背景情况:

传统化疗面临着药物耐药性,毒性和非选择性等挑战.
纳米药物输送系统 (DDS) 通过增强的透性和保留效应 (EPR) 提供了更好的疗效.
基于多糖的DDS是生物相容的,可以设计为有针对性的交付.

研究的目的:

综合审查使用生物相容多糖的氧化还原反应性DDS.
详细说明瘤微环境 (TME) 氧化还原物种 (GSH,ROS) 的利用,以触发药物释放.
为了评估各种响应群体和多糖体载体,以增强抗癌作用.

主要方法:

系统地评估氧化还原反应链接 (二硫化物,二化物,甲等). ) 的情况.
响应组与多种多糖载体的集成.
积极向策略 (例如CD44受体) 和组合疗法 (PDT,免疫疗法) 的分析.

主要成果:

红氧反应性DDS能够在瘤部位内选择性释放和激活药物.
多糖载体可以用于积极向和协同治疗方法.
设计策略可以优化,以最大限度地提高抗癌效果,并最大限度地减少非目标效应.

结论:

红氧反应性多糖体DDS是克服传统化疗局限性的有希望的策略.
仔细选择多糖载体和响应组对于优化治疗结果至关重要.
对临床翻译和人工智能驱动的设计进行进一步的研究是个性化纳米医学的必要条件.

关键词:

癌症癌症癌症癌症它是一种多糖化合物.具有ROS响应性的它们对氧化回应有反应性.

更多相关视频

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...